当前位置: 首页 >> 检索结果
6422. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
作者: Sung-Min Cho.;J Hunter Mehaffey.;Susan L Meyers.;Ryan S Cantor.;Randall C Starling.;James K Kirklin.;Jeffrey P Jacobs.;John Kern.;Ken Uchino.;Leora T Yarboro.
来源: Circulation. 2021年144卷10期763-772页
Ischemic and hemorrhagic cerebrovascular accidents remain common among patients with centrifugal-flow left ventricular assist devices, despite improvements in survival and device longevity. We compared the incidence of neurologic adverse events (NAEs) associated with 2 contemporary centrifugal-flow left ventricular assist devices: the Abbott HeartMate3 (HM3) and the Medtronic HeartWare HVAD (HVAD).
6423. Association Between Cervical Artery Dissection and Aortic Dissection.
作者: Jens Witsch.;Saad A Mir.;Neal S Parikh.;Santosh B Murthy.;Hooman Kamel.;Babak B Navi.;Alan Z Segal.;Matthew E Fink.;Stephanie B Rutrick.;Monika M Safford.;Nupoor Narula.;Parag Goyal.;Mario Gaudino.;Leonard N Girardi.;Richard B Devereux.;Mary J Roman.;Cenai Zhang.;Alexander E Merkler.
来源: Circulation. 2021年144卷10期840-842页 6424. Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy.
作者: Sami Viskin.;Ehud Chorin.;Dana Viskin.;Aviram Hochstadt.;Arie Lorin Schwartz.;Raphael Rosso.
来源: Circulation. 2021年144卷10期823-839页
Polymorphic ventricular tachyarrhythmias are highly lethal arrhythmias. Several types of polymorphic ventricular tachycardia have similar electrocardiographic characteristics but have different modes of therapy. In fact, medications considered the treatment of choice for one form of polymorphic ventricular tachycardia, are contraindicated for the other. Yet confusion about terminology, and thus diagnosis and therapy, continues. We present an in-depth review of the different forms of polymorphic ventricular tachycardia and propose a practical step-by-step approach for distinguishing these malignant arrhythmias.
6427. Response by Shah et al to Letter Regarding Article, "Cell-Free DNA to Detect Heart Allograft Acute Rejection".
作者: Palak Shah.;Sean Agbor-Enoh.;Ilker Tunc.;Steven Hsu.;Stuart Russell.;Erika Feller.;Keyur Shah.;Maria E Rodrigo.;Samer S Najjar.;Hyesik Kong.;Mehdi Pirooznia.;Ulgen Fideli.;Alfiya Bikineyeva.;Argit Marishta.;Kenneth Bhatti.;Yanqin Yang.;Cedric Mutebi.;Kai Yu.;Moon Kyoo Jang.;Charles Marboe.;Gerald J Berry.;Hannah A Valantine.; .
来源: Circulation. 2021年144卷10期e198-e199页 6429. Completeness of Linear or Fractionated Electrogram Ablation in Addition to Pulmonary Vein Isolation on Ablation Outcome: A Substudy of the STAR AF II Trial.
作者: Paula Sanchez-Somonte.;Chen-Yang Jiang.;Timothy R Betts.;Jian Chen.;Roberto Mantovan.;Laurent Macle.;Carlos A Morillo.;Wilhelm Haverkamp.;Rukshen Weerasooriya.;Jean-Paul Albenque.;Stefano Nardi.;Endrj Menardi.;Paul Novak.;Prashanthan Sanders.;Atul Verma.
来源: Circ Arrhythm Electrophysiol. 2021年14卷9期e010146页 6430. Coronary Microcirculatory Dysfunction and Acute Cellular Rejection After Heart Transplantation.
作者: Joo Myung Lee.;Ki Hong Choi.;Jin-Oh Choi.;Doosup Shin.;Yoonjee Park.;Juwon Kim.;Seung Hun Lee.;Darae Kim.;Jeong Hoon Yang.;Yang Hyun Cho.;Kiick Sung.;Ji Yeon Choi.;Meesoon Park.;Jung-Sun Kim.;Taek Kyu Park.;Young Bin Song.;Joo-Yong Hahn.;Seung-Hyuk Choi.;Hyeon-Cheol Gwon.;Jae K Oh.;Eun-Seok Jeon.
来源: Circulation. 2021年144卷18期1459-1472页
Acute cellular rejection is a major determinant of mortality and retransplantation after heart transplantation. We sought to evaluate the prognostic implications of coronary microcirculatory dysfunction assessed by index of microcirculatory resistance (IMR) for the risk of acute cellular rejection after heart transplantation.
6431. Role of Venous Endothelial Cells in Developmental and Pathologic Angiogenesis.
作者: Heon-Woo Lee.;Yanying Xu.;Liqun He.;Woosoung Choi.;David Gonzalez.;Suk-Won Jin.;Michael Simons.
来源: Circulation. 2021年144卷16期1308-1322页
Angiogenesis is a dynamic process that involves expansion of a preexisting vascular network that can occur in a number of physiological and pathological settings. Despite its importance, the origin of the new angiogenic vasculature is poorly defined. In particular, the primary subtype of endothelial cells (capillary, venous, arterial) driving this process remains undefined.
6432. Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study.
作者: Matthias Thielmann.;David Corteville.;Gabor Szabo.;Madhav Swaminathan.;Andre Lamy.;Lukas J Lehner.;Craig D Brown.;Nicolas Noiseux.;Mohamed G Atta.;Elizabeth C Squiers.;Shai Erlich.;Daniel Rothenstein.;Bruce Molitoris.;C David Mazer.
来源: Circulation. 2021年144卷14期1133-1144页
Acute kidney injury (AKI) affects up to 30% of patients undergoing cardiac surgery, leading to increased in-hospital and long-term morbidity and mortality. Teprasiran is a novel small interfering RNA that temporarily inhibits p53-mediated cell death that underlies AKI.
6434. Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria.
作者: Matteo Nardin.;Davide Cao.;Roxana Mehran.;Rishi Chandiramani.;Mauro Chiarito.;Samantha Sartori.;Hanbo Qiu.;Zhongjie Zhang.;Ekta Golani.;Johny Nicolas.;Usman Baber.;George Dangas.;Giuseppe De Luca.;Giulio G Stefanini.;Joseph Sweeny.;Samin K Sharma.;Annapoorna Kini.
来源: Circ Cardiovasc Interv. 2021年14卷9期e010392页
[Figure: see text].
6435. Evaluation of Cerebral Thromboembolism After Transcatheter Aortic Valve Replacement (EARTH TAVR): A Serial Magnetic Resonance Imaging Evaluation as Substudy of the GALILEO Trial.
作者: Georg Marcus Fröhlich.;Matthias Endres.;Volkmar Falk.;Lisa Steinbeck.;Aslihan Erbay.;Verena Stangl.;Jochen Wöhrle.;Tanja K Rudolph.;Tobias Geisler.;Henryk Dreger.;David Manuel Leistner.;Christian H Nolte.;Axel Unbehaun.;Axel Linke.;Jochen B Fiebach.;Charles Majoie.;Guido Knapp.;Karl Georg Haeusler.;Roxana Mehran.;Stephan Windecker.;George D Dangas.;Ulf Landmesser.
来源: Circ Cardiovasc Interv. 2021年14卷9期e011074页 6436. Utility of Intracardiac Echocardiography in the Early Experience of Transcatheter Edge to Edge Tricuspid Valve Repair.
作者: Mackram F Eleid.;Mohamad Alkhouli.;Jeremy J Thaden.;Firas Zahr.;Scott Chadderdon.;Mayra Guerrero.;Guy S Reeder.;Charanjit S Rihal.
来源: Circ Cardiovasc Interv. 2021年14卷10期e011118页
[Figure: see text].
6438. Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry).
作者: Wojciech Wańha.;Jacek Bil.;Rafał Januszek.;Natasza Gilis-Malinowska.;Tomasz Figatowski.;Marek Milewski.;Artur Pawlik.;Bartłomiej Staszczak.;Maciej Wybraniec.;Brunon Tomasiewicz.;Piotr Kübler.;Wiktor Kuliczkowski.;Tomasz Walczak.;Bruno Hrymniak.;Piotr Desperak.;Maksymilian Mielczarek.;Dariusz Ciecwierz.;Piotr Niezgoda.;Rafał Wolny.;Magdalena Chudzik.;Łukasz Kuźma.;Paweł Kralisz.;Elvin Kedhi.;Fabrizio D'Ascenzo.;Damian Hudziak.;Adam Kowalówka.;Grzegorz Smolka.;Krzysztof Reczuch.;Marcin Gruchała.;Jacek Kubica.;Robert J Gil.;Sławomir Dobrzycki.;Dariusz Dudek.;Stanisław Bartuś.;Mariusz Gąsior.;Andrzej Ochała.;Adam Witkowski.;Miłosz Jaguszewski.;Wojciech Wojakowski.
来源: Circ Cardiovasc Interv. 2021年14卷9期e010868页
[Figure: see text].
6439. Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease: Insights From the AFIRE Trial.
作者: Koichi Kaikita.;Satoshi Yasuda.;Masaharu Akao.;Junya Ako.;Tetsuya Matoba.;Masato Nakamura.;Katsumi Miyauchi.;Nobuhisa Hagiwara.;Kazuo Kimura.;Atsushi Hirayama.;Kunihiko Matsui.;Hisao Ogawa.
来源: Circ Cardiovasc Interv. 2021年14卷11期e010476页
Early bleeding after percutaneous coronary intervention is associated with increased risk of death and myocardial infarction; however, the association between bleeding and subsequent major adverse cardiac and cerebrovascular events (MACCE) remains unclear in patients with atrial fibrillation and stable coronary artery disease. We thus aimed to investigate this association.
6440. Response by Khalid et al to Letter Regarding Article, "Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support". |